Dear Ultrasound Insider,
Evaluating new ultrasound equipment can be an exciting and enlightening process -- even if you're one of ultrasound's pioneers. Our regular columnist Dr. Jason Birnholz recently tested a number of the latest systems and reached some interesting conclusions.
Discover what he learned -- and his thoughts on the future of ultrasound technology -- in the latest edition of his Practice of Ultrasound series, which serves as this newsletter's Insider Exclusive. You can access it before our regular members by clicking here.
In other news in your Ultrasound Digital Community, we have an update on the progress of ultrasound developer InnerVision. Founded in 2002, the company has been developing multitransmit synthetic aperture technology, which it believes yields a significant improvement in ultrasound resolution. InnerVision is now searching for corporate partners to accelerate its path to market, as reported here by editor-in-chief Brian Casey.
Thyroid cancer has been a hot topic over the past few months. Researchers from the Mayo Clinic in Rochester, MN, believe that the aggressive use of imaging could be contributing to overdiagnosis and overtreatment of certain thyroid cancers. In particular, they're calling for new nomenclature for low-risk small papillary thyroid cancers to reflect their favorable prognosis. For the details, click here.
In another study, a research team led by Dr. Rebecca Smith-Bindman, from the University of California, San Francisco, concluded that basing the decision to biopsy a thyroid nodule on the presence of certain ultrasound imaging characteristics could reduce unnecessary biopsies by 90%. What were the specific characteristics? Click here to find out.
Breast lesions categorized as BI-RADS 3 on supplemental screening ultrasound are rarely malignant and could be re-evaluated at 12 months, according to a recent study by Dr. Richard Barr, PhD, from Radiology Consultants in Youngstown, OH, and colleagues. Get the details in an article by associate editor Kate Madden Yee.
Do you have an idea for a topic you'd like to see covered? As always, please feel free to drop me a line.
